Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20791 AL 20805

Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-β-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells

Lobine D, Sadeer N, Jugreet S, Suroowan S, Keenoo BS, Imran M, Venugopala KN, Ibrahim FM, Zengin G, Mahomoodally MF.

Curr Neuropharmacol. 2021;19(9):1416-1441. doi: 10.2174/1570159X19666210412095251.

Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease

Giri B, Seamon M, Banerjee A, Chauhan S, Purohit S, Morgan J, Baban B, Wakade C.

Metab Brain Dis. 2022 Aug;37(6):1687-1696. doi: 10.1007/s11011-021-00735-2. Epub 2021 Apr 21.

Multimodal Imaging in a Patient With Alzheimer Disease and Parkinsonism Because of a Presenilin-1 Mutation

Lu JY, Sun YM, Yen TC, Zuo CT, Wang J.

Clin Nucl Med. 2021 Sep 1;46(9):e483-e484. doi: 10.1097/RLU.0000000000003674.

Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders

Hölscher C.

Br J Pharmacol. 2022 Feb;179(4):695-714. doi: 10.1111/bph.15508. Epub 2021 May 29.

Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy

Sarangi SC, Sopory P, Reeta KH.

Neurol India. 2021 Mar-Apr;69(2):252-259. doi: 10.4103/0028-3886.314522.

Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches

Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E.

Molecules. 2021 Apr 11;26(8):2193. doi: 10.3390/molecules26082193.

5-Lipoxygenase as an emerging target against age-related brain disorders

Yan M, Zhang S, Li C, Liu Y, Zhao J, Wang Y, Yang Y, Zhang L.

Ageing Res Rev. 2021 Aug;69:101359. doi: 10.1016/j.arr.2021.101359. Epub 2021 May 10.

Ocular biomarkers and their role in the early diagnosis of neurocognitive disorders

Chalkias IN, Tegos T, Topouzis F, Tsolaki M.

Eur J Ophthalmol. 2021 Nov;31(6):2808-2817. doi: 10.1177/11206721211016311. Epub 2021 May 17.

Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers

Singh AV, Chandrasekar V, Janapareddy P, Mathews DE, Laux P, Luch A, Yang Y, Garcia-Canibano B, Balakrishnan S, Abinahed J, Al Ansari A, Dakua SP.

ACS Chem Neurosci. 2021 Jun 2;12(11):1835-1853. doi: 10.1021/acschemneuro.1c00087. Epub 2021 May 19.

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Vitalakumar D, Sharma A, Flora SJS.

J Biochem Mol Toxicol. 2021 Aug;35(8):e22830. doi: 10.1002/jbt.22830. Epub 2021 May 28.

How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders

Carlson GA, Prusiner SB.

Int J Mol Sci. 2021 May 4;22(9):4861. doi: 10.3390/ijms22094861.

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis

Paolini Paoletti F, Simoni S, Parnetti L, Gaetani L.

Int J Mol Sci. 2021 May 7;22(9):4958. doi: 10.3390/ijms22094958.

Biomarkers for neurodegenerative diseases

Hansson O.

Nat Med. 2021 Jun;27(6):954-963. doi: 10.1038/s41591-021-01382-x. Epub 2021 Jun 3.

Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier

Pathan N, Shende P.

J Control Release. 2021 Jul 10;335:398-407. doi: 10.1016/j.jconrel.2021.05.046. Epub 2021 Jun 2.

New strategies for fluorescently labeling proteins in the study of amyloids

Shimogawa M, Petersson EJ.

Curr Opin Chem Biol. 2021 Oct;64:57-66. doi: 10.1016/j.cbpa.2021.04.011. Epub 2021 Jun 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias